Phathom names Anne Marie Cook as new chief legal officer

New Jersey-based biopharmaceutical company Phathom Pharmaceuticals has named Anne Marie Cook as its new chief legal officer and corporate secretary.

Cook takes up the role having previously served as SVP, general counsel of Sage Therapeutics from 2015 to 2024. 

During her tenure, Cook led all legal activities across the business, including commercialization, regulatory, compliance, intellectual property and corporate governance. 

‘I’m delighted to welcome Anne Marie Cook to Phathom, she will play a key role in shaping our corporate strategy,’ says Steven Basta, president and CEO at Phathom Pharmaceuticals.

‘Her experience and broad skills will be highly impactful as we work to build Phathom into a leading gastrointestinal company in the coming years.’

Prior to this, Cook also held the position of general counsel at Aegerion Pharmaceuticals and at ViaCell.

She also held partner roles at Choate, Hall & Stewart and Miller, Canfield Paddock & Stone.

Earlier in her career, Cook spent over ten years at Biogen, where she served as VP, chief corporate counsel.

‘I’m honored to join Phathom at such an exciting stage in its commercial evolution,’ says Cook.

‘Phathom has the potential to redefine the standard of care in acid-related GI diseases, and I’m energized by the opportunity to contribute to the company’s next chapter and to help create value for patients, physicians, and shareholders.’

Cook is based in Massachusetts, USA.

Phathom Pharmaceuticals specializes in treatments for gastrointestinal diseases and is listed on the Nasdaq exchange.